Jri Orthopaedics Limited

Osteoarthritis (OA), especially of the hip and knee, is one of the leading causes of disability across the world. Every year there are over 3 million surgical replacements of joints -- with over 0.25 million in the UK. This number is growing all the time for two reasons: 1) arthritis is exacerbated by age and body weight and the world population is gettin...

This exciting business-led project brings together industry and academia, with two commercial partners, JRI Orthopaedics (lead) and Salthaus, and the University of Sheffield. They will open new opportunities to treat hip diseases. Today there are treatments that can regrow the joint surface (known as regenerative medicine); these are only used in the knee...

The SEAMLESS project represents a major technical and commercial advance in the area ofpost processing for additive manufacturing. The poor surface quality for AM parts has been amajor barrier for full process adoption, which will be addressed in this project. The SEAMLESSsolution combines a number of surface finishing and post processing technologies inc...

Total hip replacement (THR) surgery is a common procedure, with over 80,000 procedures done each year in England and Wales. There are two types of implants: those that use bone cement and those that are cement free and bond directly to the bone called ‘uncemented’. JRI, the lead on this project, pioneered uncemented THR in the 80s and it has been highly s...

Osteoarthritis (OA) the disease that this project targets, imposes massive burden on society not only in terms of loss of quality of life for the individual, but also in terms of costs – directly to the Health Services for their treatment and indirectly from loss of earnings and impact on their carers: and it is getting worse. Despite this, treatment is o...

After years of work funded by Innovate UK, a UK partnership of two SMEs, JRI Orthopaedics and GTS are looking to scale up a new functional coating for orthopaedic implants. This will combine two successful technologies: 1) bioactive glasses and 2) 3D printed implants with complex shapes. This project will enable JRI to expand the range of its joint replac...

The FlexiFinish project addresses the significant challenges faced by industry surrounding the ability to finish surfaces on complex parts, in a controlled and cost effective manner. This is also becoming a significant barrier to the wider uptake of additive parts within the Aerospace industry and beyond. In order to address this, the FlexiFinish project ...

Additive Manufacturing (AM) has the potential to revolutionise the design, production and supply of parts, but exploitation has been limited. A major challenge for industry is to understand the true capability of the new techniques - especially making comparisons between machine platforms. The ANVIL project will overcome this issue, by bringing together k...

Early stage osteoarthritis (OA) of the knee and shoulder can be treated using Minimally Invasive Surgery (MIS), with such techniques having become widely adopted. In contrast, treatment of the OA in the hip is far more difficult as the joint is deep in the body and spherical. Variance between patients and the stiffness of the hip joint capsule and muscles...

This project brings together a consortium of complementary academic and commercial organisations, including: specialists in ultra-fast lasers, materials and orthopaedic implants. The aim is to develop new technology to allow surgeons to customise joint replacements at the time of surgery on the rare occasions when there is significant bone loss either fro...

This project brings together partners with expertise in additive manufacturing, glass technology and orthopaedic implants. The aim is to develop the next generation of coatings for orthopaedic implants such as hip replacements. The new combination glass and metal coatings will have better mechanical stability and faster integration with bone thus improvin...

To develop, evaluate and test a new, marketable, bioactive coating that will meet clinical need.